Johns Hopkins researchers helped secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to ...
This is Uganda's sixth outbreak of Ebola Sudan, which causes severe hemorrhagic fever disease with a case fatality rate of up to 50%. No licensed vaccines or therapeutics are available for Ebola Sudan ...
Hosted on MSN14h
Addressing Lassa Fever in Nigeria - the Case for Vaccines and Civil Society Engagement [blog]"When a pandemic strikes, saving lives hinges on rapid vaccine development and equitable access" -- David Agunlofi, Programme and Communications Associate at Options ConsultancyLassa fever, a viral ...
WHO and partners have immediately boosted their support to the Ugandan government's response to an outbreak of Sudan virus disease outbreak (SVD, part of the Ebola family), including by facilitating ...
Valneva's Ixchiq vaccine – which was cleared in the EU, the US, and Canada last year – is currently indicated for preventing ...
The World Health Organization (WHO) and its partners have significantly intensified their support for Uganda's response to the ongoing outbreak of Sudan virus disease (SVD), a deadly illness in the ...
The wizards at the Vaccine and Infectious Disease Organization, more commonly known as VIDO and located on the University of ...
The Saskatoon-based organization recently received a $24 million grant from the Coalition for Epidemic Preparedness ...
The Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan has been awarded a $24 million grant ...
“The clever design works by presenting fragments of several coronaviruses together to potentially induce a strong immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback